Edwards Lifesciences
693 hedge funds and large institutions have $21.4B invested in Edwards Lifesciences in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 237 increasing their positions, 263 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 692 → 693 (+1)
0.4% less ownership
Funds ownership: 256.52% → 256.11% (-0.4%)
10% less repeat investments, than reductions
Existing positions increased: 237 | Existing positions reduced: 263
Holders
693
Holding in Top 10
33
Calls
$114M
Puts
$87.6M
Top Buyers
| 1 | +$174M | |
| 2 | +$161M | |
| 3 | +$132M | |
| 4 |
Goldman Sachs
New York
|
+$106M |
| 5 |
O
OrbiMed
New York
|
+$104M |
Top Sellers
| 1 | -$197M | |
| 2 | -$88.9M | |
| 3 | -$72.3M | |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
-$70.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$69.3M |